MedCaps Menopause

Retirée du marché américain le 9 April 2025 (selon le DSLD)

XYMOGEN, food supplement from the US market

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

• Conditions légales

  Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.

  Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

• Official label: MedCaps Menopause
  Entered into DSLD on 18 July 2023. Retirée du marché américain le 8 September 2023 (selon le DSLD).

  • Same quantity, different name: Angelica sinensis Root Extract in this version; Dong Quai Root Extract on the displayed label (50 mg)

• Official label: MedCaps Menopause
  Entered into DSLD on 24 May 2017. Retirée du marché américain le 18 August 2022 (selon le DSLD).

  • Active ingredient added : Black Cohosh extract (50 mg)
  • Active ingredient added : Dong Quai extract (50 mg)
  • Active ingredient added : Wild Yam 10:1 extract (50 mg)
  • Active ingredient removed : Black Cohosh Rhizome, Root Extract (50 mg)
  • Active ingredient removed : Dong Quai Root Extract (50 mg)
  • Active ingredient removed : Wild Yam Root Extract (50 mg)
  • Same quantity, different name: Korean Ginseng extract in this version; Korean Ginseng Whole Plant Extract on the displayed label (200 mg)
  • Same quantity, different name: Licorice extract in this version; Licorice Root Extract on the displayed label (75 mg)
  • Same quantity, different name: PABA in this version; Para-Aminobenzoic Acid on the displayed label (100 mg)

• Official label: MedCaps Menopause
  Entered into DSLD on 25 August 2015. Retirée du marché américain le 8 April 2015 (selon le DSLD).

  • Active ingredient added : Black Cohosh extract (50 mg)
  • Active ingredient added : Dong Quai extract (50 mg)
  • Active ingredient added : Wild Yam 10:1 extract (50 mg)
  • Active ingredient removed : Black Cohosh Rhizome, Root Extract (50 mg)
  • Active ingredient removed : Dong Quai Root Extract (50 mg)
  • Active ingredient removed : Wild Yam Root Extract (50 mg)
  • Same quantity, different name: Korean Ginseng extract in this version; Korean Ginseng Whole Plant Extract on the displayed label (200 mg)
  • Same quantity, different name: Licorice extract in this version; Licorice Root Extract on the displayed label (75 mg)
  • Same quantity, different name: PABA in this version; Para-Aminobenzoic Acid on the displayed label (100 mg)

• Official label: MedCaps Menopause
  Entered into DSLD on 24 December 2013. Retirée du marché américain le 28 October 2014 (selon le DSLD).

  • Active ingredient added : Black Cohosh extract (50 mg)
  • Active ingredient added : Dong Quai extract (50 mg)
  • Active ingredient added : Wild Yam 10:1 extract (50 mg)
  • Active ingredient removed : Black Cohosh Rhizome, Root Extract (50 mg)
  • Active ingredient removed : Dong Quai Root Extract (50 mg)
  • Active ingredient removed : Wild Yam Root Extract (50 mg)
  • Same quantity, different name: Korean Ginseng extract in this version; Korean Ginseng Whole Plant Extract on the displayed label (200 mg)
  • Same quantity, different name: Licorice extract in this version; Licorice Root Extract on the displayed label (75 mg)
  • Same quantity, different name: PABA in this version; Para-Aminobenzoic Acid on the displayed label (100 mg)

• Official label: MedCaps Menopause
  Entered into DSLD on 23 March 2012. Retirée du marché américain le 8 September 2023 (selon le DSLD).

  • Active ingredient added : Black Cohosh Root Extract (100 mg)
  • Active ingredient added : Panax Ginseng Root Powder (400 mg)
  • Active ingredient added : Resveratrol (2,000 mcg)
  • Active ingredient added : Wild Yam Root 10:1 Extract (100 mg)
  • Active ingredient removed : Black Cohosh Rhizome, Root Extract (50 mg)
  • Active ingredient removed : Korean Ginseng Whole Plant Extract (200 mg)
  • Active ingredient removed : Trans-Resveratrol (1 mg)
  • Active ingredient removed : Wild Yam Root Extract (50 mg)
  • Different quantity per serving : Dong Quai root extract: 100 mg in this version; 50 mg on the displayed label
  • Different quantity per serving : Hesperidin: 200 mg in this version; 100 mg on the displayed label
  • Different quantity per serving : Isoflavones: 100 mg in this version; 50 mg on the displayed label
  • Different quantity per serving : Licorice Root Extract: 150 mg in this version; 75 mg on the displayed label
  • Different quantity per serving : Para Amino Benzoic Acid: 200 mg in this version; 100 mg on the displayed label
  • Different unit, without conversion : Boron: 100 mg in this version; 50 mcg on the displayed label

Source

Official label

List declared on 14 December 2023 (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

Brand : XYMOGEN